StopDownOpen the app

Acquisition · Healthcare & Life Sciences

Redcliffe Labs acquires Megavision Diagnostics for ₹40 Cr

By ·

Date
Company
Redcliffe Labs
What it does
Omnichannel diagnostics platform
Kind
Acquisition
Amount
₹40 Cr
Sector
Healthcare & Life Sciences

What they do

Redcliffe Labs is an omnichannel diagnostics platform offering over 3,600 tests across India

What happened

It has acquired Pune-based Megavision Diagnostics Centre for ₹40 Cr ($4.14 Mn), expected to close in July 2026

Why it matters

The deal follows two smaller acquisitions and a divestiture of its fertility business earlier this year

The details

  • Redcliffe Labs is acquiring Megavision Diagnostics Centre in a ₹40 Cr deal.
  • Megavision is a Pune-based diagnostics chain founded in 1996 with two centres in Pimpri and Nigdi.
  • It offers MRI, CT scans, sonography, ECG, and mammography services.
  • Megavision's annual revenue is about ₹20 Cr.
  • The transaction is expected to close later this month (July 2026).
  • Redcliffe will retain Megavision's entire workforce.
  • Weeks before this deal, Redcliffe acquired Prime Sonography and Diagnostic Center (Kota) for about ₹5 Cr and Sarvodaya Diagnostics (Ajmer) for about ₹10 Cr.
  • Earlier in 2026, Redcliffe divested its fertility business Crysta IVF to Moon Care Pvt Ltd for about ₹100 Cr.

The bigger picture

  • Redcliffe's revenue grew 12% to ₹470 Cr in FY26 from ₹418 Cr in FY25.
  • Its EBITDA loss margin narrowed to -13% in FY26 from -24% in FY25.
  • The company targets revenue of about ₹700 Cr in FY27, nearly 50% growth.
  • Redcliffe has raised $115 Mn to date from investors including LeapFrog Investments and HealthQuad.

About the business

  • Redcliffe Labs is an omnichannel diagnostics platform with over 3,600 pathology tests.
  • It offers genetic and DNA-based screening for reproductive health, cancer, and wellness.
  • The company operates in 70-80 cities across India.
  • It has 80+ self-owned certified labs and 2,000+ collection centres.
  • Home sample collection accounts for nearly half of its business.
  • Redcliffe served more than 4.3 Mn customers in FY26, conducting 24 Mn diagnostic tests.
  • 64% of its customer base comes from Tier I and II cities.
  • It provides AI-enabled diagnostic reports, consultations, and diet plans through its mobile app.

What happens next

  • Redcliffe targets revenue of about ₹700 Cr in FY27, nearly 50% year-on-year growth.

The deal

Type
acquisition

Founders

  • Aditya Kandoi, Cofounder and CEO
  • Dheeraj Jain, Cofounder and Chairman

Other articles talking about it

Read it as a card in the app

More on Redcliffe Labs

Everything on Redcliffe Labs →

Same day

All startup news on 20 July 2026 →